Targeting Sp1 and survivin for potential ovarian cancer therapy: Comparative assessment of anti-cancer NSAID tolfenamic acid and cisplatin
Meeting Abstract
Sankpal, Umesh T., Ingersoll, Susan B., Lee, Chris M., McGann, Hasina C., Bhat, Vadiraja B., Khan, Mooez, Ahmad, Sarfraz, Holloway, Robert W., Basha, Riyaz